Biofluid Biomarkers Hold Promise for the Future of Huntington Disease
April 29th 2019Currently, there are no disease-modifying medications for Huntington disease and few interventions available to effectively alleviate symptoms, while the lack of indicators of pathobiological processes at the molecular level has limited the ability to prove efficacy and safety in clinical trials.